{
    "clinical_study": {
        "@rank": "116142", 
        "acronym": "MSN", 
        "arm_group": {
            "arm_group_label": "Experimental arm", 
            "arm_group_type": "Experimental", 
            "description": "Blood sample Tumorous biopsy Healthy material sample"
        }, 
        "brief_summary": {
            "textblock": "Lung Cancer and melanoma relapsed frequently whereas its very sensitive to treatment such as\n      chemotherapy or radiotherapy. The purpose of this study is to have a better understanding of\n      why those patients are relapsing using next generation sequencing to identify rare mutations\n      and assessed their predictive value."
        }, 
        "brief_title": "Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment", 
        "completion_date": {
            "#text": "July 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Melanoma", 
            "Non Small Cell Lung Cancer", 
            "Small Cell Lung Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms", 
                "Melanoma", 
                "Small Cell Lung Carcinoma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Cytological or histological diagnosis of SCLC, NSCLC or melanoma\n\n          2. Patients age >/= 18 years old\n\n          3. Indication of treatment using platinum salts for lung cancer except for patient with\n             NSCLC treated by surgery for whom platinum salts is not indicated\n\n          4. If a biopsy is proposed, lesion lust be easily accessible\n\n          5. Signed informed consent\n\n        Exclusion Criteria:\n\n          1. Patients unable to follow the protocol\n\n          2. Consent refusal"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02105168", 
            "org_study_id": "2008-A00373-52", 
            "secondary_id": "2007/1363"
        }, 
        "intervention": [
            {
                "arm_group_label": "Experimental arm", 
                "description": "Optional", 
                "intervention_name": "Blood sample", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Experimental arm", 
                "description": "Optional", 
                "intervention_name": "Tumorous biopsy", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Experimental arm", 
                "description": "Optional", 
                "intervention_name": "Healthy material sample", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 2, 2014", 
        "location": {
            "contact": {
                "email": "benjamin.besse@gustaveroussy.fr", 
                "last_name": "Benjamin Besse, MD", 
                "phone": "0142114317", 
                "phone_ext": "+33"
            }, 
            "facility": {
                "address": {
                    "city": "Villejuif", 
                    "country": "France", 
                    "state": "Val de Marne", 
                    "zip": "94805"
                }, 
                "name": "Gustave Roussy Cancer Campus Grand Paris"
            }, 
            "investigator": {
                "last_name": "Caroline Robert, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment in Patients With Lung Cancer or Melanoma", 
        "overall_contact": {
            "email": "benjamin.besse@gustaveroussy.fr", 
            "last_name": "Benjamin Besse, MD", 
            "phone": "0142114317", 
            "phone_ext": "+33"
        }, 
        "overall_contact_backup": {
            "email": "caroline.robert@gustaveroussy.fr", 
            "last_name": "Caroline Robert, MD", 
            "phone": "0142114211", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "Gustave Roussy, Cancer Campus, Grand Paris", 
            "last_name": "Benjamin Besse, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assessed at the time of inclusion using tumorous material used for diagnosis", 
            "measure": "Mutation rate on tumorous material", 
            "safety_issue": "No", 
            "time_frame": "Assessed at the time of inclusion"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02105168"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Gustave Roussy, Cancer Campus, Grand Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Gustave Roussy, Cancer Campus, Grand Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2009", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}